Hypertension Clinical Trial
Official title:
Use of Automated Office Blood Pressure Monitoring in Older Working-age Adults
Verified date | May 2022 |
Source | University of Alabama at Birmingham |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Blood pressure measurements by three methods Office Blood Pressure Measurement (OBPM), Automated Office Blood Pressure Measurement (AOBPM), and Home Blood Pressure Measurement (HBPM) were collected retrospectively across three visits for patients (N=28) referred to a specialty hypertension (HTN) clinic. Demographic data were analyzed using summary statistics. The differences between AOBPM, HBPM, and OBPM were examined using mixed models repeated measures analysis for time and method for each visit.
Status | Completed |
Enrollment | 28 |
Est. completion date | July 5, 2021 |
Est. primary completion date | July 5, 2021 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 19 Years and older |
Eligibility | Inclusion Criteria: - 19 years and older - Uncontrolled BP - Prescribed three or more antihypertensive medications at the time of referral - Higher risk for poor CV outcomes than patients with essential HTN - OBPM systolic BP of greater than 140 mmHg and diastolic BP of greater than or equal to 90 mm Hg upon initial clinic assessment. Exclusion Criteria: - Less than 19 years old - Had a systolic BP of less than 140 mm Hg and diastolic BP of less than 90 mmHg upon initial clinic assessment. - Also, patients on less than three antihypertensive medications, with less than three visits, and who have controlled OBPM were excluded. |
Country | Name | City | State |
---|---|---|---|
United States | University of Alabama at Birmingham | Birmingham | Alabama |
Lead Sponsor | Collaborator |
---|---|
University of Alabama at Birmingham | Troy University |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Number of participants using Traditional office blood pressure measurement (OBPM) | Blood pressure control: Traditional office blood pressure measurement less than 140/90 mm Hg | Baseline | |
Primary | Number of participants using Traditional office blood pressure measurement (OBPM) | Blood pressure control: Traditional office blood pressure measurement less than 140/90 mm Hg | Up to 8 weeks | |
Primary | Number of participants using Traditional office blood pressure measurement (OBPM) | Blood pressure control: Traditional office blood pressure measurement less than 140/90 mm Hg | Up to 16 weeks | |
Primary | Number of participants using Automated office blood pressure measurement (AOBPM) | Blood pressure control: Automated office blood pressure measurement less than 130/80 mm Hg | Baseline | |
Primary | Number of participants using Automated office blood pressure measurement (AOBPM) | Blood pressure control: Automated office blood pressure measurement less than 130/80 mm Hg | Up to 8 weeks | |
Primary | Number of participants using Automated office blood pressure measurement (AOBPM) | Blood pressure control: Automated office blood pressure measurement less than 130/80 mm Hg | Up to 16 weeks | |
Primary | Number of participants using Home blood pressure measurement (HBPM) | Blood pressure control: Home blood pressure measurement less than 130/80 mm Hg | Baseline | |
Primary | Number of participants using Home blood pressure measurement (HBPM) | Blood pressure control: Home blood pressure measurement less than 130/80 mm Hg | Up to 8 weeks | |
Primary | Number of participants using Home blood pressure measurement (HBPM) | Blood pressure control: Home blood pressure measurement less than 130/80 mm Hg | Up to 16 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT04591808 -
Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia
|
Phase 3 | |
Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
Completed |
NCT05433233 -
Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension
|
N/A | |
Completed |
NCT05491642 -
A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple Doses
|
Phase 1 | |
Completed |
NCT03093532 -
A Hypertension Emergency Department Intervention Aimed at Decreasing Disparities
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Completed |
NCT05529147 -
The Effects of Medication Induced Blood Pressure Reduction on Cerebral Hemodynamics in Hypertensive Frail Elderly
|
||
Recruiting |
NCT06363097 -
Urinary Uromodulin, Dietary Sodium Intake and Ambulatory Blood Pressure in Patients With Chronic Kidney Disease
|
||
Recruiting |
NCT05976230 -
Special Drug Use Surveillance of Entresto Tablets (Hypertension)
|
||
Completed |
NCT06008015 -
A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1015" and Co-administration of "BR1015-1" and "BR1015-2" Under Fed Conditions in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT05387174 -
Nursing Intervention in Two Risk Factors of the Metabolic Syndrome and Quality of Life in the Climacteric Period
|
N/A | |
Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
Recruiting |
NCT05121337 -
Groceries for Black Residents of Boston to Stop Hypertension Among Adults Without Treated Hypertension
|
N/A | |
Withdrawn |
NCT04922424 -
Mechanisms and Interventions to Address Cardiovascular Risk of Gender-affirming Hormone Therapy in Trans Men
|
Phase 1 | |
Active, not recruiting |
NCT05062161 -
Sleep Duration and Blood Pressure During Sleep
|
N/A | |
Not yet recruiting |
NCT05038774 -
Educational Intervention for Hypertension Management
|
N/A | |
Completed |
NCT05087290 -
LOnger-term Effects of COVID-19 INfection on Blood Vessels And Blood pRessure (LOCHINVAR)
|
||
Completed |
NCT05621694 -
Exploring Oxytocin Response to Meditative Movement
|
N/A | |
Completed |
NCT05688917 -
Green Coffee Effect on Metabolic Syndrome
|
N/A | |
Recruiting |
NCT05575453 -
OPTIMA-BP: Empowering PaTients in MAnaging Blood Pressure
|
N/A |